Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges

Download All
Download slides from a live CCO symposium in which expert faculty discuss optimal treatment plans for patients with CLL/SLL while considering adverse events, biomarkers, comorbidities, and patient preferences.
Asher Chanan-Khan, MBBS, MD
Brian Hill, MD, PhD
person default
Shuo Ma, MD, PhD

Downloadable Slidesets

Download this slideset from a live symposium at ASH 2021 for expert perspectives on best practices in treating patients with newly diagnosed CLL.

Asher Chanan-Khan, MBBS, MD Released: December 9, 2021

Download this slideset from a live symposium at ASH 2021 for expert perspectives on best practices in treating patients with relapsed/refractory CLL.

Brian Hill, MD, PhD Released: December 9, 2021

Download this slideset from a live symposium at ASH 2021 to review emerging investigational agents and combination therapies in CLL.

person default Shuo Ma, MD, PhD Released: December 9, 2021

Download this short slideset of key takeaways from a live NCCN/CCO Webinar focused on current treatment in CLL/SLL.

Asher Chanan-Khan, MBBS, MD Brian Hill, MD, PhD person default Shuo Ma, MD, PhD Released: December 22, 2021
Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC
NCCN Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
BeiGene, Ltd.
Genentech, a member of the Roche Group
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings